Diane M Harper

Summary

Affiliation: Dartmouth College
Country: USA

Publications

  1. ncbi request reprint Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
    Diane M Harper
    Department of Obstetrics and Gynecology, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH, USA
    Lancet 364:1757-65. 2004
  2. ncbi request reprint Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
    Eduardo L Franco
    Division of Cancer Epidemiology, Department of Oncology and Epidemiology, McGill University, 546 Pine Avenue West, Montreal, Que, Canada H2W 1S6
    Vaccine 23:2388-94. 2005
  3. ncbi request reprint Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hannover, NH, USA
    Am J Obstet Gynecol 186:365-73. 2002
  4. ncbi request reprint Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    Diane M Harper
    Department of Obstetrics and Gynecology, Norris Cotton Cancer Center, Dartmouth Medical School, Rubin 880, One Medical Center Drive, Lebanon, NH 03756, USA
    Lancet 367:1247-55. 2006
  5. pmc Factors affecting the detection rate of human papillomavirus
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, NH, USA
    Ann Fam Med 1:221-7. 2003
  6. ncbi request reprint Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, New Hampshire, USA
    Sex Transm Dis 29:628-36. 2002
  7. doi request reprint Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, NH, USA
    Gynecol Oncol 110:S11-7. 2008
  8. ncbi request reprint Age for HPV vaccination
    Diane M Harper
    Dartmouth College, Department of Women s and Gender Studies, Obstetrics and Gynecology, Community and Family Medicine, Hanover, NH, USA
    Vaccine 26:A7-11. 2008
  9. doi request reprint Cervico-isthmic corporeal pregnancy with delivery at term: a review of the literature with a case report
    Daniel M Avery
    Department of Obstetrics and Gynecology, University of Alabama, University Medical Center, Tuscaloosa, Alabama 35401, USA
    Obstet Gynecol Surv 64:335-44. 2009
  10. ncbi request reprint Self-screening methods are the next public health improvement for sexually transmitted infection detection
    Diane M Harper
    Dartmouth Medical School, Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
    Arch Pediatr Adolesc Med 156:1154-5. 2002

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
    Diane M Harper
    Department of Obstetrics and Gynecology, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH, USA
    Lancet 364:1757-65. 2004
    ....
  2. ncbi request reprint Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
    Eduardo L Franco
    Division of Cancer Epidemiology, Department of Oncology and Epidemiology, McGill University, 546 Pine Avenue West, Montreal, Que, Canada H2W 1S6
    Vaccine 23:2388-94. 2005
    ..It will take many years before we can rationally develop cervical cancer screening strategies that will be cost-effective for the proper surveillance of women protected by HPV vaccination...
  3. ncbi request reprint Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hannover, NH, USA
    Am J Obstet Gynecol 186:365-73. 2002
    ..The purpose of this study was to compare the high-risk human papillomavirus detection rates from self-sampled swabs and tampons with standard clinician-directed speculum sampling and to assess women's acceptance of self-sampling methods...
  4. ncbi request reprint Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    Diane M Harper
    Department of Obstetrics and Gynecology, Norris Cotton Cancer Center, Dartmouth Medical School, Rubin 880, One Medical Center Drive, Lebanon, NH 03756, USA
    Lancet 367:1247-55. 2006
    ....
  5. pmc Factors affecting the detection rate of human papillomavirus
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, NH, USA
    Ann Fam Med 1:221-7. 2003
    ..The purpose of this study was to determine whether cyclic hormonal variation, recent sexual intercourse, interval between samplings, and the technique used to sample affect the detection of HPV...
  6. ncbi request reprint Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, New Hampshire, USA
    Sex Transm Dis 29:628-36. 2002
    ..Self-sampling for human papillomavirus (HPV) is useful for triage of ASCUS Papanicolaou (Pap) smears. Tampons with 10-second cervicovaginal cell exposure can detect HPV but appear to be less efficient than two consecutive swabs...
  7. doi request reprint Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age
    Diane M Harper
    Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, NH, USA
    Gynecol Oncol 110:S11-7. 2008
    ..As this vaccine is used over time in universal prophylactic HPV-16/18 vaccination of girls and women, reductions in cervical cancers at both the individual and public health levels will be appreciated...
  8. ncbi request reprint Age for HPV vaccination
    Diane M Harper
    Dartmouth College, Department of Women s and Gender Studies, Obstetrics and Gynecology, Community and Family Medicine, Hanover, NH, USA
    Vaccine 26:A7-11. 2008
    ..The need for booster shots must therefore be addressed with patients as unknown. Continued cervical cancer screening is necessary regardless of vaccination. Vaccination alone will not eliminate cervical cancer...
  9. doi request reprint Cervico-isthmic corporeal pregnancy with delivery at term: a review of the literature with a case report
    Daniel M Avery
    Department of Obstetrics and Gynecology, University of Alabama, University Medical Center, Tuscaloosa, Alabama 35401, USA
    Obstet Gynecol Surv 64:335-44. 2009
    ..However, cervico-isthmic and cervico-isthmic corporeal pregnancies are more likely to persist to an advanced gestation in the second and third trimester and cause profuse bleeding with attempted removal of the placenta...
  10. ncbi request reprint Self-screening methods are the next public health improvement for sexually transmitted infection detection
    Diane M Harper
    Dartmouth Medical School, Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
    Arch Pediatr Adolesc Med 156:1154-5. 2002
  11. ncbi request reprint Beyond the Pap: assessing patients' priorities for the annual examination
    Heidi I Becker
    Texas Tech University Health Sciences Center, El Paso, Texas, USA
    J Womens Health (Larchmt) 13:791-8. 2004
    ..The purpose of this study was to identify the reasons for an annual examination that are important to women...
  12. ncbi request reprint Interpretation of colposcopy data
    Diane M Harper
    J Fam Pract 52:390, 392; author reply 392. 2003
  13. ncbi request reprint Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
    Jorma Paavonen
    University of Helsinki, Department of Obstetrics and Gynaecology, Helsinki, Finland
    Lancet 369:2161-70. 2007
    ....
  14. ncbi request reprint Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
    Elmar A Joura
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Lancet 369:1693-702. 2007
    ..Our aim was to do a combined analysis of three randomised clinical trials to assess the effect of a prophylactic quadrivalent HPV vaccine on the incidence of these diseases...
  15. ncbi request reprint Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
    Luisa L Villa
    Department of Virology, Ludwig Institute for Cancer Research, R Prof Antonio Prudente 109, 4th Floor, 01509 010 Sao Paulo, SP, Brazil
    Vaccine 24:5571-83. 2006
    ..Following an initial, similar sized decline, anti-HPV responses plateaued and remained stable through end-of-study (3.0 years). No vaccine-related serious adverse experiences were reported...
  16. ncbi request reprint Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study
    Warner K Huh
    University of Alabama at Birmingham, Birmingham, Alabama 35233 7333, USA
    Am J Obstet Gynecol 190:1249-57. 2004
    ..The purpose of this study was to assess the in vivo optical detection of high-grade cervical intraepithelial neoplasia (2/3+) on the whole cervix with a noncontact, spectroscopic device...
  17. ncbi request reprint Are we closer to the prevention of HPV-related diseases?
    Diane M Harper
    Gynecologic Cancer Prevention Research Group, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH USA
    J Fam Pract . 2005
  18. ncbi request reprint Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
    Luisa L Villa
    Department of Virology, Ludwig Institute for Cancer Research, Sao Paulo, Brazil
    Lancet Oncol 6:271-8. 2005
    ....
  19. ncbi request reprint Why am I scared of HPV?
    Diane M Harper
    CA Cancer J Clin 54:245-7. 2004